White House pushes new rules for medium-sized banks without Congress

White House pushes new rules for medium-sized banks without Congress

WASHINGTON, March 30 (Reuters) – The Biden administration has urged banking authorities to tighten regulation of medium-sized banks, which it said could be implemented without support from a divided Congress. Banks with between $100 billion and $250 billion in assets should hold more liquid assets, increase their capital, undergo regular stress tests and write “living … Read more

Apple wins US patent appeal in $502 million VirnetX judgment

Apple wins US patent appeal in 2 million VirnetX judgment

March 30 (Reuters) – Apple Inc (AAPL.O) on Thursday persuaded a US appeals court to uphold a patent tribunal ruling that could jeopardize a $502 million judgment for patent licensing company VirnetX Inc in its long-running battle of the companies for privacy software technology. The U.S. Court of Appeals for the Federal Circuit upheld a … Read more

Explainer: how a massive options trade by a JP Morgan fund can move markets

Explainer: how a massive options trade by a JP Morgan fund can move markets

NEW YORK, Sept. 29 (Reuters) – A nearly $16 billion JP Morgan fund is expected to reset its options positions on Friday, possibly adding to stock volatility at the end of a dismal quarter for equities. Analysts have historically pointed out that the JPMorgan Hedged Equity Fund’s quarterly reset has been troubled markets, seeing this … Read more

FTX’s Bankman-Fried pleads not guilty to campaign finance, bribery charges in China

FTX’s Bankman-Fried pleads not guilty to campaign finance, bribery charges in China

NEW YORK, March 30 (Reuters) – Indicted founder of the FTX cryptocurrency exchange, Sam Bankman-Fried, pleaded not guilty on Thursday to fresh US charges of conspiracy to violate campaign finance laws and bribe Chinese authorities. Bankman-Fried, 31, entered the plea for the new 13 count indictment at a hearing before U.S. District Judge Lewis Kaplan … Read more

As weight loss drugs enter the US market, doctors debate their use

As weight loss drugs enter the US market, doctors debate their use

30 March (Reuters) – As powerful new anti-obesity drugs hit the US market, medical associations are eager to advise their members on how best to use them for patients. That’s where the debate begins. Some specialists advocate the wide use of drugs such as Novo Nordisk’s (NOVOb.CO) Wegovy, in addition to a healthy diet and … Read more